Exclusion of participants based on substance use status: Findings from randomized controlled trials of treatments for PTSD
- PMID: 27846419
- DOI: 10.1016/j.brat.2016.10.006
Exclusion of participants based on substance use status: Findings from randomized controlled trials of treatments for PTSD
Abstract
Individuals with posttraumatic stress disorder (PTSD) are more than four times as likely as those without PTSD to have substance use disorder (SUD), making it critical to understand the interaction of substance use status and PTSD outcomes. Using the broader treatment literature, we examined PTSD treatment effects, with and without co-morbid SUD, by extending a published meta-analysis to include recent studies. From reports of 156 Randomized Controlled Trials (RCTs), we extracted exclusion criteria based on substance use and findings involving substance use as a predictor or outcome. Almost three-quarters of RCT designs excluded participants based on substance use status. Only 29.5% reported descriptive statistics characterizing substance use within the study sample and only 7.7% reported substance use-related outcomes. There was no clear relationship between exclusion criteria based on substance use and PTSD outcome or participant retention, suggesting either that SUD does not impede treatment effects, or that available studies lack sufficient data for these analyses. Importantly, no studies reported significant increases in substance use in the course of PTSD treatment. We conclude that patients with PTSD and co-morbid SUD have been largely neglected in PTSD RCTs; thus findings may not be fully applicable to those meeting criteria for both conditions.
Keywords: Alcohol; Clinical trial; Comorbidity; Drug; Multimorbidity; Pharmacotherapy; Psychotherapy; Substance use disorder.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes?Drug Alcohol Depend. 2019 Jun 1;199:70-75. doi: 10.1016/j.drugalcdep.2019.04.001. Epub 2019 Apr 9. Drug Alcohol Depend. 2019. PMID: 31009834 Free PMC article. Clinical Trial.
-
No Wrong Doors: Findings from a Critical Review of Behavioral Randomized Clinical Trials for Individuals with Co-Occurring Alcohol/Drug Problems and Posttraumatic Stress Disorder.Alcohol Clin Exp Res. 2017 Apr;41(4):681-702. doi: 10.1111/acer.13325. Epub 2017 Feb 10. Alcohol Clin Exp Res. 2017. PMID: 28055143 Review.
-
Inclusion and exclusion criteria in randomized controlled trials of psychotherapy for PTSD.J Psychiatr Pract. 2014 Jan;20(1):25-37. doi: 10.1097/01.pra.0000442936.23457.5b. J Psychiatr Pract. 2014. PMID: 24419308 Review.
-
Helping vulnerable populations: a comprehensive review of the treatment outcome literature on substance use disorder and PTSD.J Clin Psychol. 2013 May;69(5):433-79. doi: 10.1002/jclp.21980. J Clin Psychol. 2013. PMID: 23592045 Review.
-
Co-morbid post-traumatic stress disorder in a substance misusing clinical population.Drug Alcohol Depend. 2005 Mar 7;77(3):251-8. doi: 10.1016/j.drugalcdep.2004.08.017. Drug Alcohol Depend. 2005. PMID: 15734225
Cited by
-
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence.BJPsych Open. 2024 Mar 12;10(2):e62. doi: 10.1192/bjo.2024.13. BJPsych Open. 2024. PMID: 38468390 Free PMC article.
-
Cannabis use and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data.J Anxiety Disord. 2024 Mar;102:102827. doi: 10.1016/j.janxdis.2024.102827. Epub 2024 Jan 10. J Anxiety Disord. 2024. PMID: 38266511 Free PMC article.
-
Project harmony: A systematic review and network meta-analysis of psychotherapy and pharmacologic trials for comorbid posttraumatic stress, alcohol, and other drug use disorders.Psychol Bull. 2024 Mar;150(3):319-353. doi: 10.1037/bul0000409. Epub 2023 Nov 16. Psychol Bull. 2024. PMID: 37971855
-
Factors Associated with High-Risk Substance Use in Persons Receiving Psychiatric Treatment for a Primary Trauma- and Stressor-Related Disorder Diagnosis.J Dual Diagn. 2023 Oct-Dec;19(4):199-208. doi: 10.1080/15504263.2023.2260340. Epub 2023 Nov 1. J Dual Diagn. 2023. PMID: 37796639
-
Early intervention using written exposure therapy for PTSD and AUD symptoms following sexual assault: Description of design and methodology.Contemp Clin Trials. 2023 Feb;125:107002. doi: 10.1016/j.cct.2022.107002. Epub 2022 Nov 24. Contemp Clin Trials. 2023. PMID: 36436732 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical